Why is Syncom Formul. falling/rising?

As of 24-Jun, Syncom Formulations (India) Ltd has seen its stock price rise to 19.64, reflecting an increase of 0.64 or 3.37%. Despite a recent decline of 3.06% over the past week, the stock has shown positive performance over the last month with a gain of 0.82%. Today's price summary indicates that the stock outperformed its sector by 3.16%, although there has been a notable decrease in investor participation, with delivery volume falling by 62.58% compared to the 5-day average. The company has demonstrated strong financial performance, with a net profit growth of 36.08% and consistent positive results over the last four quarters, contributing to a significant increase in net sales and profit after tax.
In the broader market context, while the stock has underperformed the benchmark Sensex in the short term, it has outperformed it over the longer term, generating a return of 52.37% over the past year compared to the Sensex's 6.10%. This long-term performance, alongside a low debt-to-equity ratio and substantial growth in key financial metrics, suggests that the stock remains a solid investment despite recent fluctuations. The liquidity of the stock is adequate for trading, indicating that while there may be short-term volatility, the underlying fundamentals support a positive outlook for Syncom Formulations.